(Q42877990)

English

Imatinib treatment of metastatic GIST: don't stop (believing).

scientific article published on 21 September 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

9 November 2017

Imatinib treatment of metastatic GIST: don't stop (believing). (English)

1 reference

stated in

Europe PubMed Central

9 November 2017

1 reference

1

1 reference

stated in

Europe PubMed Central

9 November 2017

21 September 2010

1 reference

stated in

Europe PubMed Central

9 November 2017

Lancet Oncology Commission

1 reference

stated in

Europe PubMed Central

9 November 2017

11

1 reference

stated in

Europe PubMed Central

9 November 2017

10

1 reference

stated in

Europe PubMed Central

9 November 2017

910-911

1 reference

stated in

Europe PubMed Central

9 November 2017

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970225-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970225-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970225-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of chronic myeloid leukaemia.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970225-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukemia stem cells in a genetically defined murine model of blast-crisis CML.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970225-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Kitlow stem cells cause resistance to Kit/platelet-derived growth factor alpha inhibitors in murine gastrointestinal stromal tumors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970225-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S1470-2045(10)70225-4

1 reference

stated in

Europe PubMed Central

9 November 2017

1 reference

Europe PubMed Central

PubMed ID

20864404

retrieved

9 November 2017

(Q42877990)

Imatinib treatment of metastatic GIST: don't stop (believing).

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)